New Developments in Anthracycline-Induced Cardiotoxicity

E-ISSN： 1875-533x|16|13|1656-1672

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.13, 2009-05, pp. : 1656-1672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anthracycline-Induced Cardiotoxicity in Children with Cancer: Strategies for Prevention and Management

By Iarussi Diana

Pediatric Drugs, Vol. 7, Iss. 2, 2005-01 ,pp. : 67-76

Adis International

Access to resources Recommend Favorite

Anthracycline cardiotoxicity

By Jones Robin L Swanton Charles Ewer Michael S

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 791-809

Informa Healthcare

Access to resources Recommend Favorite

Serum total antioxidant status (TAOS) and brain natriuretic peptide (BNP) levels may be useful in the early diagnosis of anthracycline-induced cardiotoxicity

Reactions Weekly, Vol. 1, Iss. 1153, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs

Drug Design Reviews - Online, Vol. 2, Iss. 4, 2005-01 ,pp. : 267-276

Bentham Science Publishers

Access to resources Recommend Favorite

Carvedilol appears to protect against anthracycline-induced cardiomyopathy

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite